ALEXANDER MOSES: Open Payments
NPI 1649893637 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 22 payments from 13 companies in 2025. Trend: 2023 $259 · 2024 $473 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Exact Sciences Corporation | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: FANAPT, INGREZZA, JARDIANCE, CREON, Cologuard Collection Kit, MAVYRET, REXULTI, MOUNJARO.
Industry payments across MT — which companies pay providers there.
